Back to NBIX
Candriam S.C.A. NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$49.1M
Q3 2026
Peak value
$49.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $40.4M |
| Q4 2025 | $41.6M |
| Q4 2025 | $41.6M |
| Q1 2026 | $36.2M |
| Q2 2026 | $43.9M |
| Q3 2026 | $49.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $49.1M | 344.9K | — | — |
| Q2 2026 | $43.9M | 260.9K | — | — |
| Q1 2026 | $36.2M | 275.1K | — | — |
| Q4 2025 | $41.6M | 293.1K | — | — |
| Q4 2025 | $41.6M | 293.1K | — | — |
| Q3 2025 | $40.4M | 287.6K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M